Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Approves Biggest Biosimilar Yet

The third biosimilar to receive FDA approval is Novartis’ answer to Enbrel, Amgen’s blockbuster that sold $9.5 billion last year.

Sandoz / Photo: pharmaobserver.com
Sandoz / Photo: pharmaobserver.com

A recent FierceBiotech article discussed the FDA’s approval of the rheumatoid arthritis and psoriasis biosimilar to Enbrel. The drug will be marketed under the name Erelzi, and is the third biosimilar approved in the U.S. The first was Novartis’ Zarxio- rival to Amgen’s Neupogen. Novartis’ generic division, Sandoz, is planning three more FDA submissions for biosimilars in the next two years for Amgen’s Epogen, AbbVie’s Humira, and Roche’s Rituxan.

“The biosimilar pathway is an important mechanism to improve access to treatment for patients with rheumatic and autoimmune diseases,” said Dr. Janet Woodcock,director of the FDA’s Center for Drug Evaluation and Research. Not to be outdone, Amgen is launching its own biosimilar strategy targeting Humira, but AbbVie is making its own legal patent case to defend it.

Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report